| Primary |
| Urinary Tract Infection |
39.5% |
| Dysuria |
18.4% |
| Atrial Fibrillation |
5.3% |
| Prostate Cancer |
5.3% |
| Back Pain |
2.6% |
| Bladder Cancer |
2.6% |
| Bladder Disorder |
2.6% |
| Bladder Pain |
2.6% |
| Burning Sensation |
2.6% |
| Cystitis |
2.6% |
| Cystitis Interstitial |
2.6% |
| Pain |
2.6% |
| Pollakiuria |
2.6% |
| Urinary Tract Disorder |
2.6% |
| Urinary Tract Pain |
2.6% |
| Urticaria |
2.6% |
|
| Sulphaemoglobinaemia |
12.9% |
| Renal Failure Acute |
9.7% |
| Chest Pain |
6.5% |
| Erythema |
6.5% |
| Methaemoglobinaemia |
6.5% |
| Pyrexia |
6.5% |
| Urticaria |
6.5% |
| Yellow Skin |
6.5% |
| Anaemia |
3.2% |
| Burning Sensation |
3.2% |
| Chills |
3.2% |
| Dizziness |
3.2% |
| Dyspnoea |
3.2% |
| Feeling Abnormal |
3.2% |
| Gait Disturbance |
3.2% |
| Haemolytic Anaemia |
3.2% |
| Lip Swelling |
3.2% |
| Muscle Spasms |
3.2% |
| Oxygen Saturation Decreased |
3.2% |
| Pancreatitis |
3.2% |
|
| Secondary |
| Urinary Tract Infection |
22.2% |
| Product Used For Unknown Indication |
19.8% |
| Accidental Exposure |
6.2% |
| Atrial Fibrillation |
5.6% |
| Suicide Attempt |
5.6% |
| Urinary Retention |
5.6% |
| Nasopharyngitis |
4.9% |
| Depression |
3.1% |
| Nausea |
3.1% |
| Prophylaxis |
3.1% |
| Blood Cholesterol Increased |
2.5% |
| Contraception |
2.5% |
| Dysuria |
2.5% |
| Insomnia |
2.5% |
| Kidney Infection |
2.5% |
| Cardiac Disorder |
1.9% |
| Diarrhoea |
1.9% |
| Hypertension |
1.9% |
| Pyrexia |
1.9% |
| Constipation |
1.2% |
|
| Completed Suicide |
12.1% |
| Depression |
12.1% |
| Pulmonary Malformation |
9.1% |
| Drug Hypersensitivity |
6.1% |
| Methaemoglobinaemia |
6.1% |
| Unresponsive To Stimuli |
6.1% |
| Urinary Tract Infection |
6.1% |
| Urticaria |
6.1% |
| Abnormal Withdrawal Bleeding |
3.0% |
| Amenorrhoea |
3.0% |
| Asthenia |
3.0% |
| Blood Bilirubin Increased |
3.0% |
| Cardiac Arrest |
3.0% |
| Decreased Appetite |
3.0% |
| Dizziness |
3.0% |
| Drug Interaction |
3.0% |
| Fall |
3.0% |
| Gingival Bleeding |
3.0% |
| Haemorrhage |
3.0% |
| Hyponatraemia |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.2% |
| Drug Use For Unknown Indication |
12.4% |
| Pain |
11.8% |
| Contraception |
6.2% |
| Depression |
6.1% |
| Urinary Tract Infection |
4.9% |
| Breast Cancer |
4.3% |
| Anxiety |
3.8% |
| Hypertension |
3.7% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Premenstrual Syndrome |
2.8% |
| Restless Legs Syndrome |
2.8% |
| Oral Contraception |
2.7% |
| Diabetes Mellitus |
2.6% |
| Breast Cancer Metastatic |
2.5% |
| Osteoporosis |
2.3% |
| Premedication |
2.1% |
| Infection Prophylaxis |
2.1% |
| Acne |
2.0% |
| Sleep Disorder |
1.9% |
|
| Vomiting |
12.1% |
| Urinary Tract Infection |
11.7% |
| Weight Decreased |
10.2% |
| Pain |
7.9% |
| Type 2 Diabetes Mellitus |
6.8% |
| Cholelithiasis |
5.7% |
| White Blood Cell Count Decreased |
5.3% |
| Nausea |
4.5% |
| Crohn's Disease |
4.2% |
| Cholecystitis Chronic |
3.8% |
| Weight Increased |
3.8% |
| Anxiety |
3.4% |
| Injury |
3.4% |
| Diarrhoea |
2.6% |
| Pulmonary Embolism |
2.6% |
| Stomach Discomfort |
2.6% |
| Tremor |
2.6% |
| Deep Vein Thrombosis |
2.3% |
| Palpitations |
2.3% |
| Pneumonia |
2.3% |
|
